Literature DB >> 15591028

Peripherally administered [Nle4,D-Phe7]-alpha-melanocyte stimulating hormone increases resting metabolic rate, while peripheral agouti-related protein has no effect, in wild type C57BL/6 and ob/ob mice.

N Hoggard1, D V Rayner, S L Johnston, J R Speakman.   

Abstract

The melanocortin system coordinates the maintenance of energy balance via the regulation of both food intake and energy expenditure. Leptin, a key adipogenic hormone involved in the regulation of energy balance is thought to act by stimulating production, in the hypothalamic arcuate nucleus, of alpha-melanocyte stimulating hormone (alphaMSH), a potent agonist of MC3/4 melanocortin receptors located in the paraventricular nucleus of the hypothalamus. Additionally leptin inhibits release of agouti-related protein (AgRP), an MC4R antagonist. During periods of caloric restriction, weight loss is not sustained because compensatory mechanisms, such as reduced resting metabolic rate (RMR) are brought into play. Understanding how these compensatory systems operate may provide valuable targets for pharmaceutical therapies to support traditional dieting approaches. As circulating leptin is reduced during caloric restriction, it may mediate some of the observed compensatory responses. In addition to decreases in circulating leptin levels, circulating AgRP is increased during fasting in rodents while alphaMSH is decreased. As central administration of AgRP depresses metabolism, we hypothesised that the peripheral rise in AgRP might be involved in signalling the depression of RMR during food restriction. We hypothesised that changes in plasma AgRP and alphaMSH may coordinate the regulation of changes in energy expenditure acting through central MC4 melanocortin receptors via the sympathetic nervous system.We show here that acute peripherally administered AgRP at supra-physiological concentrations in both lean (C57BL/6) and obese leptin-deficient (ob/ob) mice does not depress RMR, possibly because it crosses the blood-brain barrier very slowly compared with other metabolites. However, in vitro AgRP can decrease leptin secretion, by approximately 40%, from adipocytes into culture medium and may via this axis have an effect on energy metabolism during prolonged caloric restriction. In contrast, peripheral [Nle4,D-Phe7]-alpha MSH produced a large and sustained increase in resting energy expenditure (0.15 ml O2/min; P < 0.05) with a similar response in leptin-deficient ob/ob mice (0.27 ml O2/min) indicating that this effect is independent of the status of leptin production in the periphery. In both cases respiratory exchange ratio and the levels of energy expended on spontaneous physical activity were unaffected by the administration of peripheral [Nle4,D-Phe7]-alpha MSH. In conclusion, alphaMSH analogues that cross the blood-brain barrier may significantly augment dietary restriction strategies by sustaining elevated RMR.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15591028     DOI: 10.1677/jme.1.01632

Source DB:  PubMed          Journal:  J Mol Endocrinol        ISSN: 0952-5041            Impact factor:   5.098


  14 in total

1.  Influence of a novel inhibitor (UM8190) of prolylcarboxypeptidase (PRCP) on appetite and thrombosis.

Authors:  F M Rabey; R S V S Gadepalli; S Diano; Q Cheng; T Tabrizian; D Gailani; J M Rimoldi; Z Shariat-Madar
Journal:  Curr Med Chem       Date:  2012       Impact factor: 4.530

2.  Angiotensin AT1A receptors on leptin receptor-expressing cells control resting metabolism.

Authors:  Kristin E Claflin; Jeremy A Sandgren; Allyn M Lambertz; Benjamin J Weidemann; Nicole K Littlejohn; Colin M L Burnett; Nicole A Pearson; Donald A Morgan; Katherine N Gibson-Corley; Kamal Rahmouni; Justin L Grobe
Journal:  J Clin Invest       Date:  2017-03-06       Impact factor: 14.808

3.  Phosphodiesterase inhibitor-dependent inverse agonism of agouti-related protein on melanocortin 4 receptor in sea bass (Dicentrarchus labrax).

Authors:  Elisa Sánchez; Vera Cruz Rubio; Darren Thompson; Juriaan Metz; Gert Flik; Glenn L Millhauser; José Miguel Cerdá-Reverter
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-02-18       Impact factor: 3.619

4.  Development of an assay for high-throughput energy expenditure monitoring in the zebrafish.

Authors:  Benjamin J Renquist; Chao Zhang; Savannah Y Williams; Roger D Cone
Journal:  Zebrafish       Date:  2013-05-25       Impact factor: 1.985

5.  Biphasic effect of melanocortin agonists on metabolic rate and body temperature.

Authors:  Beth Lute; William Jou; Dalya M Lateef; Margalit Goldgof; Cuiying Xiao; Ramón A Piñol; Alexxai V Kravitz; Nicole R Miller; Yuning George Huang; Clemence Girardet; Andrew A Butler; Oksana Gavrilova; Marc L Reitman
Journal:  Cell Metab       Date:  2014-06-26       Impact factor: 27.287

6.  Fibroblast growth factor 21 is a metabolic regulator that plays a role in the adaptation to ketosis.

Authors:  Eleni M Domouzoglou; Eleftheria Maratos-Flier
Journal:  Am J Clin Nutr       Date:  2011-02-23       Impact factor: 7.045

Review 7.  The role of the Agouti-Related Protein in energy balance regulation.

Authors:  O Ilnytska; G Argyropoulos
Journal:  Cell Mol Life Sci       Date:  2008-09       Impact factor: 9.261

8.  Relationship between basal metabolic rate and cortisol secretion throughout pregnancy.

Authors:  Svetozar S Damjanovic; Rada V Stojic; Nebojsa M Lalic; Aleksandra Z Jotic; Djuro P Macut; Sanja I Ognjanovic; Milan S Petakov; Bojana M Popovic
Journal:  Endocrine       Date:  2009-01-21       Impact factor: 3.633

9.  Central blockade of melanocortin receptors attenuates the metabolic and locomotor responses to peripheral interleukin-1beta administration.

Authors:  Keith W Whitaker; Teresa M Reyes
Journal:  Neuropharmacology       Date:  2007-11-05       Impact factor: 5.250

10.  Measuring energy metabolism in the mouse - theoretical, practical, and analytical considerations.

Authors:  John R Speakman
Journal:  Front Physiol       Date:  2013-03-14       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.